NEW YORK, March 6 - Zyomyx today said that Aventis has agreed to buy one of its Protein Profiling Biochip systems.

The tool consists of Zyomyx's first protein profiling biochip--called the Human Cytokine Biochip--as well as the Assay 1200 automated workstation and the Scanner 100 reader and data-analysis software.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.